Your Health, We Care

Home >Drug List>Niraparib>Indications of Niraparib

Niraparib(Zejula)

Release date: 2026-01-05 14:04:26     Recommended: 32

It is indicated for the treatment of relapsed or refractory acute leukemia (with KMT2A translocation) or relapsed or refractory acute myeloid leukemia (with NPM1 mutation) in adult patients and pediat